Lentiviral Vectors as a Gene Delivery System in the Mouse Midbrain: Cellular and Behavioral Improvements in a 6-OHDA Model of Parkinson's Disease Using GDNF

By Bensadoun J.-C.   Deglon N.   Tseng J.L.   Ridet J.-L.   Zurn A.D.   Aebischer P.  

Experimental Neurology, Vol. 164, Iss. 1, 2000-07 ,pp. : 15-24

Elsevier

Access to resources Recommend Favorite

Structural and functional neuroprotection in a rat model of Huntington's disease by viral gene transfer of GDNF

By McBride J.L.   During M.J.   Wuu J.   Chen E.-Y.   Leurgans S.E.   Kordower J.H.  

Experimental Neurology, Vol. 181, Iss. 2, 2003-06 ,pp. : 213-223

Elsevier

Access to resources Recommend Favorite

GDNF treatment in Parkinson’s disease: time for controlled clinical trials?

By Brundin Patrik  

Brain, Vol. 125, Iss. 10, 2002-10 ,pp. : 2149-2151

Oxford University Press

Access to resources Recommend Favorite

Studies on Neuroprotective and Regenerative Effects of GDNF in a Partial Lesion Model of Parkinson's Disease

By Bjorklund A.   Rosenblad C.   Winkler C.   Kirik D.  

Neurobiology of Disease, Vol. 4, Iss. 3, 1997-03 ,pp. : 186-200

Academic Press

Access to resources Recommend Favorite

Heparin Coinfusion during Convection-Enhanced Delivery (CED) Increases the Distribution of the Glial-Derived Neurotrophic Factor (GDNF) Ligand Family in Rat Striatum and Enhances the Pharmacological Activity of Neurturin

By Hamilton J.F.   Morrison P.F.   Chen M.Y.   Harvey-White J.   Pernaute R.S.   Phillips H.   Oldfield E.   Bankiewicz K.S.  

Experimental Neurology, Vol. 168, Iss. 1, 2001-03 ,pp. : 155-161

Elsevier

Access to resources Recommend Favorite